• This record comes from PubMed

Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes

. 2020 ; 15 (1) : e0226606. [epub] 20200113

Language English Country United States Media electronic-ecollection

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/pmid31929543

BACKGROUND: The objective of this study was to assess regional and ethnic differences in an unselected patient population treated with polymer-free sirolimus-eluting stents (PF-SES) in Asia and Europe. METHODS: Two all-comers observational studies based on the same protocol (ClinicalTrials.gov Identifiers: NCT02629575 and NCT02905214) were combined for data analysis to assure sufficient statistical power. The primary endpoint was the accumulated target lesion revascularization (TLR) rate at 9-12 months. RESULTS: Of the total population of 7243 patients, 44.0% (3186) were recruited in the Mediterranean region and 32.0% (2317) in central Europe. The most prominent Asian region was South Korea (17.6%, 1274) followed by Malaysia (5.7%, 413). Major cardiovascular risk factors varied significantly across regions. The overall rates for accumulated TLR and MACE were low with 2.2% (140/6374) and 4.4% (279/6374), respectively. In ACS patients, there were no differences in terms of MACE, TLR, MI and accumulated mortality between the investigated regions. Moreover, dual antiplatelet therapy (DAPT) regimens were substantially longer in Asian countries even in patients with stable coronary artery disease as compared to those in Europe. CONCLUSIONS: PF-SES angioplasty is associated with low clinical event rates in all regions. Further reductions in clinical event rates seem to be associated with longer DAPT regimens.

See more in PubMed

Ananthakrishna R, Kristanto W, Liu L, Chan SP, Loh PH, Tay EL, et al. Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry. Catheter Cardiovasc Interv. 2018;92:1097–1103. 10.1002/ccd.27577 PubMed DOI

Klomp M, Damman P, Beijk MA, Tan KH, Balian V, de Luca G, et al.; e-HEALING investigators. Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy. Coron Artery Dis. 2012;23:271–277. 10.1097/MCA.0b013e328351aaed PubMed DOI

Pepe M, Biondi-Zoccai G, Corcione N, Nestola PL, Ferraro P, Morello A, et al. Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions. Am J Cardiol. 2019. April 23 pii: S0002–9149(19)30454-0. 10.1016/j.amjcard.2019.04.015 PubMed DOI

Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, et al. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.Circ Cardiovasc Interv. 2016;9(7). pii: e003610 10.1161/CIRCINTERVENTIONS.115.003610 PubMed DOI

Yeh RW, Silber S, Chen L, Chen S, Hiremath S, Neumann FJ, et al. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program. JACC Cardiovasc Interv. 2017;10: 247–254. 10.1016/j.jcin.2016.11.004 PubMed DOI

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–260. 10.1093/eurheartj/ehx419 PubMed DOI

Bae JS, Ahn JH, Tantry US, Gurbel PA, Jeong YH. Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? Curr Vasc Pharmacol. 2018;16:459–476. 10.2174/1570161116666180117103238 PubMed DOI

Krackhardt F, Kočka V, Waliszewski MW, Utech A, Lustermann M, Hudec M, et al. Polymer-free sirolimus-eluting stents in a large-scale all-comers population. Open Heart. 2017;4:e000592 10.1136/openhrt-2017-000592 PubMed DOI PMC

Krackhardt F, Rosli MA, Leschke M, Schneider A, Sperling C, Heang TM, et al. Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture. Catheter Cardiovasc Interv. 2018;91:1221–1228. 10.1002/ccd.27306 PubMed DOI

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al.; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344–2351 10.1161/CIRCULATIONAHA.106.685313 PubMed DOI

Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials. Circulation. 2011;123:2736–2747. 10.1161/CIRCULATIONAHA.110.009449 PubMed DOI

Sperling C, Waliszewski MW, Kherad B, Krackhardt F. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries. Ther Adv Cardiovasc Dis. 2019. Jan-Dec;13:1753944719826335 10.1177/1753944719826335 PubMed DOI PMC

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–2619. 10.1093/eurheartj/ehu278 PubMed DOI

Wöhrle J, Zadura M, Möbius-Winkler S, Leschke M, Opitz C, Ahmed W, et al. SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol. 2012;60:1733–1738. 10.1016/j.jacc.2012.07.040 PubMed DOI

Leschke M, Waliszewski M, Pons M, Champin S, Nait Saidi L, Mok Heang T, et al. A Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS? Catheter Cardiovasc Interv. 2016;88:358–366. 10.1002/ccd.26261 PubMed DOI

Mehran R, Chandrasekhar J, Davis S, Nathan S, Hill R, Hearne S, et al. Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women. Circ Cardiovasc Interv. 2019;12(4):e006918 10.1161/CIRCINTERVENTIONS.118.006918 PubMed DOI

Inohara T, Kohsaka S, Goto M, Furukawa Y, Fukushima M, Sakata R et al. Hypothesis of Long-Term Outcome after Coronary Revascularization in Japanese Patients Compared to Multiethnic Groups in the US. PLoS One. 2015;10:e0128252 10.1371/journal.pone.0128252 PubMed DOI PMC

van Oeffelen AA, Rittersma S, Vaartjes I, Stronks K, Bots ML, Agyemang C. Are There Ethnic Inequalities in Revascularisation Procedure Rate after an ST-Elevation Myocardial Infarction? PLoS One. 2015;10(9):e0136415 10.1371/journal.pone.0136415 PubMed DOI PMC

Tong J, Xiang WW, Ang AS, Sim WJ, Quah KH, Foo D, et al. Clinical outcomes of elderly South-East Asian patients in primary percutaneous coronary intervention for ST-elevation myocardial infarction. J Geriatr Cardiol. 2016;13:830–835. 10.11909/j.issn.1671-5411.2016.10.001 PubMed DOI PMC

Leschke M, Nhan VT, Waliszewski M, Palacios V, Horváth I, Ivanov VA, et al. The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia—an overall and transcontinental assessment of the 10-month major adverse cardiac events. Indian Heart J. 2012;64:453–461. 10.1016/j.ihj.2012.08.002 PubMed DOI PMC

Reddon H, Patel Y, Turcotte M, Pigeyre M, Meyre D. Revisiting the evolutionary origins of obesity: lazy versus peppy-thrifty genotype hypothesis. Obes Rev. 2018;19:1525–1543. 10.1111/obr.12742 PubMed DOI

Hickman PE, Lindahl B, Cullen L, Koerbin G, Tate J, Potter JM. Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician. Crit Rev Clin Lab Sci. 2015;52:28–44. 10.3109/10408363.2014.972497 PubMed DOI

Pepe M, Sardella G, Stefanini GG, Corcione N, Nestola PL, Morello A, et al. Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry). Am J Cardiol. 2019. November 15;124(10):1518–1527. 10.1016/j.amjcard.2019.08.015 PubMed DOI

See more in PubMed

ClinicalTrials.gov
NCT02629575, NCT02905214

Back

Find record

Citation metrics

Archiving options